Alfa Laval wins SEK90m pharmaceutical order in India
To supply a processing line for a new insulin plant in Malaysia
Alfa Laval, a leading provider of specialised products and engineering solutions based on its key technologies of heat transfer, centrifugal separation and fluid handling, has won an order from a major pharmaceutical company in India to supply a processing line for a new insulin plant in Malaysia.
The order is worth approximately SEK90m (€10.4m; US$13.3m) and delivery is scheduled for 2014.
The order includes a variety of Alfa Laval equipment for fermentation, fluid handling and tank cleaning, forming a complete processing line for insulin production.
‘The pharmaceutical industry requires hygienic and safe equipment that comply with the rigorous industry standards. This order is driven by the increased living standard and confirms our position as a reliable supplier to the industry,’ said Lars Renström, president and ceo of the Alfa Laval Group.
Alfa Laval’s equipment, systems and services are dedicated to assisting customers in optimising the performance of their processes. The solutions help them to heat, cool, separate and transport products in industries that produce food and beverages, chemicals and petrochemicals, pharmaceuticals, starch, sugar and ethanol.
